Yuxin Zhang

Ms. Yuxin Zhang

Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
LXLei Xu
Lei Xu
YZYuxin Zhang
Yuxin Zhang
PZPei Zhang
Pei Zhang
XDXiaomin Dai
Xiaomin Dai
YGYiqiao Gao
Yiqiao Gao
Fengguo XuFengguo Xu
Fengguo Xu

26 September 2021 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
XHXiaoying Hou
Xiaoying Hou
PZPei Zhang
Pei Zhang
HDHong‐Zhi Du
Hong‐Zhi Du
YGYi‐Qiao Gao
Yi‐Qiao Gao
RSRui‐Qi Sun
Rui‐Qi Sun
Fengguo XuFengguo Xu
Fengguo Xu
Click on the article title to read more.

23 May 2019 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
WHWanqiu Huang
Wanqiu Huang
YXYazhou Xu
Yazhou Xu
YZYuxin Zhang
Yuxin Zhang
PZPei Zhang
Pei Zhang
QZQianqian Zhang
Qianqian Zhang
Fengguo XuFengguo Xu
Fengguo Xu

28 June 2023 in Analytica Chimica Acta
Verified
Journal Article
Closed access
STShaoran Tang
Shaoran Tang
PZPei Zhang
Pei Zhang
MGMeiyu Gao
Meiyu Gao
QXQinwen Xiao
Qinwen Xiao
ZLZhaoqian Li
Zhaoqian Li
YZYuxin Zhang
Yuxin Zhang

1 February 2022 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
SQSiyuan Qin
Siyuan Qin
YZYuxin Zhang
Yuxin Zhang
YTYuan Tian
Yuan Tian
Fengguo XuFengguo Xu
Fengguo Xu
PZPei Zhang
Pei Zhang

9 August 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
YZYing Zhang
Ying Zhang
DWDi Wang
Di Wang
BLBo Lv
Bo Lv
XHXiaoying Hou
Xiaoying Hou
QLQiwei Liu
Qiwei Liu
PZPei Zhang
Pei Zhang
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers with high mortality worldwide. Type 2 diabetes mellitus (T2D), known as a risk factor of CRC, can promote the deterioration of CRC, but the underlying mechanism is elusive. In this study, we aimed to reveal the relationship between CRC and T2D from the perspective of small-molecule metabolism. First, a list of common dysregulated metabolites in CRC and T2D was obtained by retrieving existing metabolomics publications. Among these metabolites, oleic acid (OA) was found to be able to promote the proliferation and migration of colon carcinoma cell HCT116. Further experiments proved that insulin could significantly strengthen this promotion and showed a synergistic effect with OA. Mechanism study found that OA and insulin acted synergistically through the extracellular signal-regulated kinase (ERK)1/2/c-Myc/cyclin D1 pathway. In addition, the combination of ERK1/2 inhibitor SCH772984 and cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib showed a remarkable inhibitory effect on tumor growth in vivo. Taken together, the current study found that OA plays an important role in CRC development by using a functional metabolomics approach. More importantly, insulin and OA were confirmed to synergistically promote the deterioration of CRC in vitro and in vivo via ERK1/2/c-Myc/cyclin D1 pathway. Our findings may shed light on CRC treatment among the T2D population.